Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics reported after the close of the market on Wednesday that its fourth quarter revenues rose 22 percent.

For the three-month period ended Dec. 31, Interpace's revenues were $3.1 million, compared $2.6 million the prior year.

"2016 was a breakout year as we delivered strong revenue growth, significant cost reductions and right sizing as we completed our transition to a fully-integrated, commercially based molecular diagnostics company," Interpace President and CEO Jack Stover said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.